Abstract
Aim of the study: To determine the correlation between plasma hs-CRP concentration with GRACE risk score and the benefit of combining these two values in predicting in-hospital mortality of patients with acute coronary syndromes. Patients and methods: We performed an observational case-series in patients admitted to the Kien Giang general hospital with a diagnosis of acute coronary syndrome from October 2014 to April 2015. Plasma hs-CRP concentration was measured in a blood sample collected on admission. All patients were evaluated with the GRACE risk score. Area under the ROC curve, sensitivity and specificity of plasma hs-CRP concentration in predicting mortality were defined. The coefficient of correlation between plasma hs-CRP concentration and the GRACE score was calculated. In high-risk patients (GRACE score > 140), mortality of the two subgroups with plasma hs-CRP concentration above and below the threshold was compared. Results: 153 patients were included (8% had unstable angina, 21% had NSTEMI and 71% had STEMI). Patients’ mean age was 67,8, and 54,1% were men. 15 patients died (mortality 9,8%). Plasma hs-CRP concentration of these 15 patients was significantly higher compared to patients who survived. Area under the ROC curve was 0,868 (0,790-0,960). Plasma hs-CRP concentration ≥ 11,5 mg/l had a sensitivity of 93% and a specificity of 62% in predicting mortality. The coefficient of correlation r was 0,46 (p < 0,001). In high-risk patients, in-hospital mortality of the subgroups with plasma hs-CRP concentration ≥ 11,5 mg/l and < 11,5 mg/l was 27,4% and 2,9% (OR 12,9; p < 0,0001). Conclusions: In patients with acute coronary syndromes, the measurement of plasma hs-CRP concentration on admission greatly contributed to the prediction of in-hospital mortality, especially in patients with a high risk according to the GRACE score.